Deep Light Vision – revolutionizing healthcare with Ultrasound Optical Tomography, offering real-time, non-invasive imaging of tissue oxygenation. By addressing critical gaps in neonatal care, cancer, stroke, and more, our technology has the potential to offer early detection, faster, more accurate diagnoses, improving patient outcomes and enabling earlier interventions.
The technology comes from research at the Department of Physics at Lund University. The new medical imaging method, Ultrasound Optical Tomography (UOT), uses a combination of ultrasound, laser spectroscopy and quantum sensors to take detailed pictures of the oxygen levels in the body. This can give doctors the unique advantage of seeing oxygenation deep into the body with good image quality, through the use of a mobile device that can be placed in an emergency department or clinic.
The technology has the potential to make it easier and faster to get important information about a patient’s health in conditions where rapid diagnosis is crucial, such as stroke or heart attack. The functional imaging also opens up the possibility of non-invasive or “digital” biopsy, i.e. providing functional information inside an organ without physical sampling.
The management consists of consists of Stefan Kröll, Professor at Lund University; Anders Sjögren, who has worked as CEO and CTO in various companies, including Lumito, Avsalt, and TEQCool; Johannes Swartling, who has experience from companies such as SpectraCure, Gasporox, Neola Medical, and NanoEcho; Tomas Kramar, former CEO of Siemens Healthineers Sweden; Masoud Khayyami, a well-known entrepreneur in life science companies in Lund; and Per Kroll, a software technology executive with experience working in startups (Objectory), mid-sized companies (Enator, Rational Software), and global corporations (Broadcom, IBM).
A first UOT prototype system has been developed and tested with so-called tissue phantoms that mimic the properties of biological tissue. The tests have shown that the technology performs as planned. In the next step, a clinical research study is planned with tests on humans.
Traditional imaging techniques such as X-ray, magnetic camera technology and ultrasound cannot image oxygenation in tissues and blood vessels in a simple way. Oxygenation is of vital importance for human survival and deficiencies in oxygenation are the cause of life-threatening acute conditions such as stroke and heart attack, which together constitute the cause of the majority of all deaths.
Deep Light Vision was founded based on research at the Department of Physics at Lund University by a research group led by Professor Stefan Kröll. The company’s management team consists of Stefan Kröll; Anders Sjögren, who has worked as CEO and CTO in several companies, including Lumito, Avsalt, and TEQCool; Johannes Swartling, who has experience from companies such as SpectraCure, Gasporox, GPX Medical, and NanoEcho; Tomas Kramar, former CEO of Siemens Healthineers Sweden; Masoud Khayyami, a well-known Lund-based entrepreneur in life science companies; and Per Kröll, a software technology executive with experience from working at Broadcom and IBM.
DEEP LIGHT VISION AB
Gasverksgatan 1
222 29 Lund Sweden
info@deeplightvision.com